Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

bristol laboratories ltd. - ibuprofen - filmovertrukne tabletter - 400 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - lamotrigin - tabletter - 100 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - lamotrigin - tabletter - 200 mg

Denmaki - Kidenmaki - Lægemiddelstyrelsen (Danish Medicines Agency)

mylan ab - lamotrigin - tabletter - 50 mg

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

roche registration gmbh  - pralsetinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

takeda pharma a/s - brigatinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. alunbrig is indicated as monotherapy for the treatment of adult patients with anaplastic lymphoma kinase alkpositive advanced nsclc previously treated with crizotinib.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

sanofi winthrop industrie - teriflunomide - multipel sclerose - selektive immunosuppressiva - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

roche registration gmbh - mycophenolatmofetil - graft afvisning - immunosuppressiva - cellcept er indiceret i kombination med ciclosporin og kortikosteroider til profylakse af akut transplantafstødning hos patienter, som modtager allogene nyre-, hjerte- eller levertransplantater.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

sanofi-aventis groupe - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - antitrombotiske midler - akut koronar syndromemyocardial myokardieinfarkt.

Umoja wa Ulaya - Kidenmaki - EMA (European Medicines Agency)

pfizer europe ma eeig - dacomitinib monohydrat - carcinom, ikke-småcellet lunge - antineoplastiske midler - vizimpro, som monoterapi, er angivet for den første linje behandling af voksne patienter med lokalt fremskreden eller metastatisk ikke-småcellet lungekræft (nsclc) med epidermal growth factor receptor (egfr) aktiverende mutationer.